PL3908270T3 - Połączenie dekstrometomorfanu i bupropionu do leczenia depresji u pacjentów pochodzenia azjatyckiego - Google Patents
Połączenie dekstrometomorfanu i bupropionu do leczenia depresji u pacjentów pochodzenia azjatyckiegoInfo
- Publication number
- PL3908270T3 PL3908270T3 PL20737928.0T PL20737928T PL3908270T3 PL 3908270 T3 PL3908270 T3 PL 3908270T3 PL 20737928 T PL20737928 T PL 20737928T PL 3908270 T3 PL3908270 T3 PL 3908270T3
- Authority
- PL
- Poland
- Prior art keywords
- dextromethorphan
- bupropion
- combination
- treating depression
- asian patients
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962789431P | 2019-01-07 | 2019-01-07 | |
| US201962789488P | 2019-01-07 | 2019-01-07 | |
| US201962789451P | 2019-01-07 | 2019-01-07 | |
| US201962789446P | 2019-01-07 | 2019-01-07 | |
| PCT/US2020/012612 WO2020146412A1 (en) | 2019-01-07 | 2020-01-07 | Combination of dextromethorphan and bupropion for treating depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3908270T3 true PL3908270T3 (pl) | 2026-02-16 |
Family
ID=71521902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20737928.0T PL3908270T3 (pl) | 2019-01-07 | 2020-01-07 | Połączenie dekstrometomorfanu i bupropionu do leczenia depresji u pacjentów pochodzenia azjatyckiego |
Country Status (28)
| Country | Link |
|---|---|
| EP (2) | EP4631571A3 (pl) |
| JP (1) | JP2022516361A (pl) |
| KR (2) | KR20210110654A (pl) |
| CN (4) | CN114712358A (pl) |
| AU (3) | AU2020207261B2 (pl) |
| BR (1) | BR112020025902A2 (pl) |
| CA (2) | CA3223187A1 (pl) |
| CL (1) | CL2021001810A1 (pl) |
| CO (1) | CO2021008988A2 (pl) |
| CR (1) | CR20210368A (pl) |
| DK (1) | DK3908270T3 (pl) |
| EC (1) | ECSP21051833A (pl) |
| ES (1) | ES3051232T3 (pl) |
| FI (1) | FI3908270T3 (pl) |
| HR (1) | HRP20251402T1 (pl) |
| IL (1) | IL284663A (pl) |
| LT (1) | LT3908270T (pl) |
| MX (1) | MX2021008247A (pl) |
| MY (1) | MY201603A (pl) |
| NZ (1) | NZ777261A (pl) |
| PE (1) | PE20212249A1 (pl) |
| PL (1) | PL3908270T3 (pl) |
| PT (1) | PT3908270T (pl) |
| RS (1) | RS67453B1 (pl) |
| SG (1) | SG11202106392RA (pl) |
| SI (1) | SI3908270T1 (pl) |
| SM (1) | SMT202600055T1 (pl) |
| WO (1) | WO2020146412A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12109178B2 (en) | 2013-11-05 | 2024-10-08 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11433067B2 (en) | 2013-11-05 | 2022-09-06 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11534414B2 (en) | 2013-11-05 | 2022-12-27 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US12194006B2 (en) | 2013-11-05 | 2025-01-14 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11969421B2 (en) | 2013-11-05 | 2024-04-30 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US12569479B2 (en) | 2016-05-25 | 2026-03-10 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| KR20210110654A (ko) * | 2019-01-07 | 2021-09-08 | 안테씨프 바이오벤쳐스 투 엘엘씨 | 우울증 치료를 위한 덱스트로메토르판과 부프로피온의 조합 |
| US20250073188A1 (en) | 2020-06-05 | 2025-03-06 | Antecip Bioventures Ii Llc | Compounds and combinations thereof for treating neurological and psychiatric conditions |
| US12472156B2 (en) | 2020-06-05 | 2025-11-18 | Antecip Bioventures Ii Llc | Compounds and combinations thereof for treating neurological and psychiatric conditions |
| US12433884B2 (en) | 2020-06-05 | 2025-10-07 | Antecip Bioventures Ii Llc | Compounds and combinations thereof for treating neurological and psychiatric conditions |
| KR20230113787A (ko) | 2020-12-01 | 2023-08-01 | 안테씨프 바이오벤쳐스 투 엘엘씨 | 우울증 환자의 자살 위험 감소를 위한 부프로피온 및덱스트로메토르판 |
| JP2024526896A (ja) * | 2021-07-21 | 2024-07-19 | アンテシップ バイオベンチャーズ トゥー エルエルシー | うつ病の治療 |
| CN117813083A (zh) * | 2021-08-09 | 2024-04-02 | 安泰赛普生物风投二代有限责任公司 | 维持抑郁症状缓解的方法 |
| CN119212709A (zh) * | 2022-05-17 | 2024-12-27 | 安泰赛普生物风投二代有限责任公司 | 抑郁的治疗 |
| US12156914B2 (en) | 2022-06-30 | 2024-12-03 | Axsome Therapeutics, Inc. | Pharmaceutical compositions comprising bupropion and cysteine |
| US12036191B1 (en) | 2022-06-30 | 2024-07-16 | Antecip Bioventures Ii Llc | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan |
| US11717518B1 (en) | 2022-06-30 | 2023-08-08 | Antecip Bioventures Ii Llc | Bupropion dosage forms with reduced food and alcohol dosing effects |
| US11844797B1 (en) | 2023-04-20 | 2023-12-19 | Antecip Bioventures Ii Llc | Combination of dextromethorphan and bupropion for treating depression |
| US12194036B2 (en) | 2022-07-07 | 2025-01-14 | Antecip Bioventures Ii Llc | Combination of dextromethorphan and bupropion for treating depression |
| US11730706B1 (en) | 2022-07-07 | 2023-08-22 | Antecip Bioventures Ii Llc | Treatment of depression in certain patient populations |
| WO2025117954A1 (en) * | 2023-12-01 | 2025-06-05 | Axsome Therapeutics, Inc. | Compounds and combinations thereof for treating depression in patients |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2641392A1 (en) * | 2006-02-03 | 2007-08-16 | Avanir Pharmaceuticals | Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders |
| SG11201502425WA (en) * | 2012-10-11 | 2015-05-28 | Ix Biopharma Ltd | Solid dosage form |
| WO2014120936A2 (en) * | 2013-01-30 | 2014-08-07 | Pharmorx Therapeutics, Inc. | Treatments for depression and other diseases with a low dose agent |
| US10512643B2 (en) * | 2013-11-05 | 2019-12-24 | Antecip Bioventures Ii Llc | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
| CN110327338A (zh) * | 2013-11-05 | 2019-10-15 | 安泰赛普生物风投二代有限责任公司 | 包含安非他酮或相关化合物和右美沙芬的组合物和方法 |
| US9402843B2 (en) * | 2013-11-05 | 2016-08-02 | Antecip Bioventures Ii Llc | Compositions and methods of using threohydroxybupropion for therapeutic purposes |
| CN117427077A (zh) * | 2014-09-14 | 2024-01-23 | 阿瓦尼尔制药股份有限公司 | 用于治疗痴呆中的激越行为的包含右美沙芬化合物和奎尼丁的药物组合物 |
| PT3220909T (pt) * | 2014-11-21 | 2020-12-07 | Antecip Bioventures Ii Llc | Bupropiona para modular os níveis plasmáticos de fármaco de dextrometorfano |
| KR20210110654A (ko) * | 2019-01-07 | 2021-09-08 | 안테씨프 바이오벤쳐스 투 엘엘씨 | 우울증 치료를 위한 덱스트로메토르판과 부프로피온의 조합 |
-
2020
- 2020-01-07 KR KR1020217023974A patent/KR20210110654A/ko not_active Ceased
- 2020-01-07 EP EP25191016.2A patent/EP4631571A3/en active Pending
- 2020-01-07 PE PE2021001138A patent/PE20212249A1/es unknown
- 2020-01-07 FI FIEP20737928.0T patent/FI3908270T3/fi active
- 2020-01-07 PL PL20737928.0T patent/PL3908270T3/pl unknown
- 2020-01-07 WO PCT/US2020/012612 patent/WO2020146412A1/en not_active Ceased
- 2020-01-07 NZ NZ777261A patent/NZ777261A/en unknown
- 2020-01-07 LT LTEPPCT/US2020/012612T patent/LT3908270T/lt unknown
- 2020-01-07 SI SI202030682T patent/SI3908270T1/sl unknown
- 2020-01-07 SG SG11202106392RA patent/SG11202106392RA/en unknown
- 2020-01-07 DK DK20737928.0T patent/DK3908270T3/da active
- 2020-01-07 KR KR1020247038482A patent/KR20240169131A/ko active Pending
- 2020-01-07 CA CA3223187A patent/CA3223187A1/en active Pending
- 2020-01-07 PT PT207379280T patent/PT3908270T/pt unknown
- 2020-01-07 CA CA3126062A patent/CA3126062C/en active Active
- 2020-01-07 AU AU2020207261A patent/AU2020207261B2/en active Active
- 2020-01-07 MX MX2021008247A patent/MX2021008247A/es unknown
- 2020-01-07 CN CN202210286769.9A patent/CN114712358A/zh active Pending
- 2020-01-07 ES ES20737928T patent/ES3051232T3/es active Active
- 2020-01-07 CN CN202210286767.XA patent/CN114712357A/zh active Pending
- 2020-01-07 SM SM20260055T patent/SMT202600055T1/it unknown
- 2020-01-07 RS RS20251154A patent/RS67453B1/sr unknown
- 2020-01-07 CN CN202080004041.1A patent/CN112437659B/zh active Active
- 2020-01-07 HR HRP20251402TT patent/HRP20251402T1/hr unknown
- 2020-01-07 CN CN202210286580.XA patent/CN114712356A/zh active Pending
- 2020-01-07 CR CR20210368A patent/CR20210368A/es unknown
- 2020-01-07 EP EP20737928.0A patent/EP3908270B1/en active Active
- 2020-01-07 JP JP2021539451A patent/JP2022516361A/ja active Pending
- 2020-01-07 BR BR112020025902-0A patent/BR112020025902A2/pt not_active Application Discontinuation
- 2020-01-07 MY MYPI2021003336A patent/MY201603A/en unknown
-
2021
- 2021-07-06 IL IL284663A patent/IL284663A/en unknown
- 2021-07-07 CL CL2021001810A patent/CL2021001810A1/es unknown
- 2021-07-07 CO CONC2021/0008988A patent/CO2021008988A2/es unknown
- 2021-07-13 EC ECSENADI202151833A patent/ECSP21051833A/es unknown
-
2023
- 2023-07-06 AU AU2023204348A patent/AU2023204348B2/en active Active
-
2025
- 2025-05-23 AU AU2025203831A patent/AU2025203831A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3908270T1 (sl) | Kombinacija dekstrometorfana in bupropiona za zdravljenje depresije pri azijskih bolnikih | |
| GB2590793B (en) | Cannabidiol-C1 for use as a medicament and in the treatment of epilepsy | |
| SG10201908697XA (en) | A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease | |
| PT3545948T (pt) | Utilização de aglomerado de ouro ou substância que contém aglomerado de ouro na preparação de droga para prevenção e/ou tratamento de glaucoma | |
| IL282871A (en) | Systems and methods for skin care | |
| EP3250609A4 (en) | Il13ra alpha 2 binding agents and use thereof in cancer treatment | |
| SG10202002898RA (en) | A Pharmaceutical Composition For Use In The Treatment Or Prevention Of A C5-Related Disease And A Method For Treating Or Preventing A C5-Related Disease | |
| SG11202108331XA (en) | Adjustable expiratory relief in respiratory therapy | |
| IL266623A (en) | A pharmaceutical preparation for use in the therapeutic treatment of cancer and complications of cancer | |
| GB2588994B (en) | Combar for skin and hair treatment | |
| EA201390287A1 (ru) | Теобромин в комбинации с отхаркивающим или муколитическим средствами для применения в терапии | |
| EP3848032A4 (en) | APPLICATION OF PYRROLOQUINOLINE QUINONE IN THE PREPARATION OF A MEDICINE USED FOR PREVENTING AND TREATING ACUTE ALTITUDE SICKNESS AND ACUTE ALTITUDE HYPOXIC INJURY | |
| GB201919200D0 (en) | Use of mir-12 in preparation of drugs for treating intrauterine adhesion and/or thin endometrum | |
| SG11202008914WA (en) | A platform and system for use in therapeutic procedures | |
| PT3937949T (pt) | Fitoecdisonas e seus derivados para utilização no tratamento da alteração da função respiratória | |
| ES3062513T3 (en) | Factor ix variants and uses thereof in therapy | |
| IL267534A (en) | Low dose drug combinations for use in preventing and treating neuronal damage | |
| ZA201806864B (en) | Use of an acetylcholinesterase inhibitor and idalopirdine for reducing falls in parkinson's disease patients | |
| ZA201804198B (en) | Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body | |
| PL3515399T3 (pl) | Kompozycja kosmetyczna lub farmaceutyczna do pielęgnacji skóry, poprawy stanu skóry i redukcji zmarszczek | |
| IL288905A (en) | diagnosis and treatment | |
| SG11202112877XA (en) | Surface treatment agent and method for manufacturing surface treatment body | |
| SG11202107221UA (en) | Curved needle and curved catheter | |
| SG11202000509PA (en) | Nanostructured and biocompatible biocatalysts for use in cancer treatment | |
| HK40075731A (en) | Lnp-formulated mrna therapeutics and use thereof for treating human subjects |